0001522860FALSE00015228602024-01-172024-01-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________
FORM 8-K
_________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 15, 2024
_________________________________________
Picture1.jpg
Acutus Medical, Inc.
(Exact name of Registrant as Specified in Its Charter)
_________________________________________
Delaware001-3943045-1306615
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
2210 Faraday Ave., Suite 100
Carlsbad, CA
92008
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: (442) 232-6080
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
_________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock, par value $0.001AFIBThe Nasdaq Stock Market LLC
(Nasdaq Capital Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
1

2

Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
        Compensatory Arrangements of Certain Officers.

On January 15, 2024, R. Scott Huennekens, a Class II director and chairperson of the Board of Directors (the “Board”) of Acutus Medical, Inc. (the “Company”), resigned from the Board, including as chairperson of the Board, effective January 15, 2024.

The resignation of Mr. Huennekens was not due to a disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

On January 15, 2024, the Board appointed Shaden Marzouk, a class II director, as independent chairperson of the Board, effective January 15, 2024.

In addition, effective January 15, 2024 the Board has fixed the size of the Board at six members, with two Class I directors, two Class II directors and two Class III directors.
Item 9.01.    Financial Statements and Exhibits.
(d)Exhibits
Exhibit
Number
Description
104.0Cover Page Interactive Data File (embedded within the Inline XBRL document)
3

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Acutus Medical, Inc.
Date: January 17, 2024By:
/s/ Tom Sohn
Tom Sohn, Chief Administrative Officer, General Counsel and Secretary
4
v3.23.4
Cover
Jan. 17, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jan. 15, 2024
Entity Registrant Name Acutus Medical, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39430
Entity Tax Identification Number 45-1306615
Entity Address, Address Line One 2210 Faraday Ave.
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Carlsbad
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92008
City Area Code 442
Local Phone Number 232-6080
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001
Trading Symbol AFIB
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001522860
Amendment Flag false
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Acutus Medical Charts.
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Acutus Medical Charts.